Searchable abstracts of presentations at key conferences in endocrinology

ea0016p223 | Diabetes and cardiovascular diseases | ECE2008

Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in polycystic ovary syndrome

Vrbikova Jana , Hill Martin , Vondra Karel , Bendlova Bela , Grimmichova Tereza , Dvorakova Katerina , Stanicka Sonja , Pacini Giovanni

Insulin hypersecretion during oral or intravenous glucose tolerance test (OGTT, ivGTT) was described previously in women with polycystic ovary syndrome (PCOS). Little attention was given to the regulation of insulin secretion in these subjects. We aimed to study the secretion of incretins (glucose-dependent insulinotropic polypeptide, GIP, glucagon-like peptide 1, GLP-1), during OGTT in normoglucose-tolerant PCOS women.After signing written informed cons...

ea0016p530 | Obesity | ECE2008

Fluctuation of orexin, ghrelin and melatonin levels during daytime

Racz Beata , Duskova Michaela , Vondra Karel , Simunkova Katerina , Nedvidkova Jara , Sedlackova Dana , Hill Martin , Starka Luboslav

Introduction: Melatonin plays a key role in the circadian timing system. The question remains whether changes in endogenous melatonin may be associated with food intake. Orexin and ghrelin are involved in the regulation of energetic homeostasis. Therefore, we decided to obtain more detailed data on the circadian changes of orexin, ghrelin and melatonin for identification of the changes in these hormones to food intake and day-time, together with glycemic and C-peptide levels.<...

ea0016p645 | Reproduction | ECE2008

Serum osteoprotegerin in polycystic ovary syndrome

Zajickova Katerina , Hill Martin , Dvorakova Katerina , Stanicka Sona , Vondra Karel , Vrbikova Jana

Osteoprotegerin (OPG) is a potent inhibitor of osteoclastic bone resorption. Besides osteoblasts, OPG is expressed by both endothelial and vascular smooth muscle cells. Moreover, elevated serum OPG has been found in conditions associated with insulin resistance such as obesity, diabetes and/or Cushing syndrome.The aim of the present study was to investigate the relationship between serum OPG and insulin resistance in women with polycystic ovary syndrome ...

ea0014p508 | (1) | ECE2007

Levels of serum and salivary cortisol during low dose ACTH test in young adult-onset diabetes mellitus Type 1 patients

Simunkova Katerina , Vondra Karel , Hampl Richard , Hill Martin , Kvasnickova Hana , Vrbikova Jana , Starka Luboslav

Detailed information on adrenal function in autoimmune Type 1 diabetes with onset in adults is still lacking. This work aimed at gathering own data on adrenal response to low-dose (1 μg) ACTH in blood and saliva.Twenty-three diabetics were investigated; age 44±10 yrs (mean ± S.D.), age at diagnosis 28.5±10 yr, disease duration 15±8 yr, BMI 24.5±2.7 kg/cm2, HbA1c 7.2±1.2%....

ea0014p614 | (1) | ECE2007

Family history of diabetes mellitus determines insulin sensitivity and beta cell dysfunction in polycystic ovary syndrome

Vrbikova Jana , Dvorakova Katerina , Grimmichova Tereza , Hill Martin , Stanicka Sona , Vondra Karel

Aim: To examine the secretion of insulin and glucagon in PCOS in the context of insulin sensitivity.Patients and methods: 13 healthy women (BMI 21.8(2.2) kg/m2), 21 PCOS without family history of DM2 (FH-); BMI 24.3 (4.4) kg/m2 and 16 PCOS with the 1st degree relative affected by DM2 (FH+); BMI 26.7 (4.2) kg/m2. Euglyceamic hyperinsulinaemic clamp (1mIU kg−1.min−1; with the determination ...

ea0014p615 | (1) | ECE2007

Retinol-binding protein-4 in polycystic ovary synrome - relationship with obesity and androgen levels

Vrbikova Jana , Hill Martin , Bendlova Bela , Grimmichova Tereza , Dvorakova Katerina , Vondra Karel

Aim and background: Retinol binding protein 4 (RBP 4) is an adipocyte-secreted molecule causing insulin resistance in transgenic animals. RBP was increased in subjects with impaired glucose tolerance and diabetes type 2. The levels of RBP-4 in PCOS were not investigated till now.Subjects and methods16 lean PCOS (BMI 21.4 (1.75) kg/m2, age 24.1 (4.1) years), 25 obese PCOS (BMI 30.3 (4.8) kg/m2, age 26.3 (5.0) years) and 13 healthy wo...

ea0013p43 | Clinical practice/governance and case reports | SFEBES2007

Severe hyponatraemia – how low can you go?

Joseph Franklin , Kaliyaperumal Mohanraj , Moss Nicole , Qedwai Farhan , Hill Carol , Khaleeli AA

A 64 year old man presented with confusion and agitation following diarrhoea for 48 hours. He had a background history of hypertension, type 2 diabetes, depression and had a normal sodium concentration of 135 mmol/L a year prior to admission. His medications included bendroflumethiazide and sertraline in addition to metformin, diclofenac sodium, aspirin, simvastatin, nifedipine and enalapril. On examination he was conscious but confused. He was afebrile with a blood pressure o...

ea0013p220 | AMEND Young Investigator's Award | SFEBES2007

Diagnosing early acromegaly: the pre-test probability of disease is strongly influenced by the presence or absence of other associated diseases

Bhattacharya Beas , Syed Akheel , Razvi Salmon , Johnson K , Hill J , Carrie S , Mitra D , Quinton Richard

A 44-year-old man referred with erectile dysfunction was found to have hypogonadotrophic hypogonadism (HH), but otherwise apparently normal anterior pituitary function (LH 1.6 & FSH 2.7 IU/l; T 3.4 & cortisol 516 nmol/l; PRL 103, GH 5.5 & TSH 2.8 mU/l; f-T4 13, f-T3 4.8 & f-T 128 pmol/l; ferritin 103 ug/l). He appeared normally virilised, with central obesity (BMI 36 kg.m−2, collar size 46 cm) and symptomatic sleep apnoea (SA). MRI showed a rig...

ea0012oc21 | Pituitary, ovary and steroids | SFE2006

Macroprolactinoma with progressive resistance to high-dose cabergoline

Arun CS , Mitra Dip , Ball Steve , Hill John , Lewis Joanna , Quinton Richard

IntroductionTrue resistance to cabergoline in patients with hyperprolactinaemia has only rarely been reported. We describe a patient with macroprolactinoma who initially responded to cabergoline, but then developed a progressive increase in PRL levels.Clinical caseA 78-year-old male presenting with headache and left temporal hemianopia was found to have a macroprolactinoma with suprasellar/cavernous sinus ext...

ea0011p366 | Diabetes, metabolism and cardiovascular | ECE2006

Is there male androgenetic alopecia the sign of male equivalent of polycystic ovary syndrome or metabolic syndrome?

Duskova M , Starka L , Hill M , Dolezal M , Simunkova K , Cermakova I

Introduction: Androgenetic alopecia (AGA) is the most common cause of balding in men. AGA is the risk factor of cardiovascular diseases, glucose metabolism disorders and also the risk of benign prostethyperplasia and prostate carcinoma. Polycystic ovary syndrome (PCOS) and metabolic syndrome are the risk factors of insulin resistance, obesity and diabetes mellitus. The genetic autosomal trait of PCOS initiated a hypothesis about the existence of a male equivalent of PCOS. Prem...